Rimag

About Rimag

Rimag, officially Jiangxi Rimag Group Co., Ltd., is a prominent medical imaging services provider in China, established in 2014 by founders including Wang Shihe and Gu Junjun. Wang Shihe's journey began as a doctor in a public hospital before he transitioned into business in 2002, founding a company that became a distributor for GE's medical imaging equipment in China, providing him with deep industry insight. Rimag has evolved into a key player in China's third-party medical imaging market, recently achieving a significant milestone by listing on the Hong Kong Stock Exchange in June 2024.

The company operates a network of independent medical imaging centers across China, addressing the critical need for advanced diagnostic services, particularly in lower-tier cities and county-level regions where hospitals often lack the capital to purchase and maintain expensive imaging equipment. As of late 2023, Rimag's network consisted of 97 imaging centers, making it the largest in China by number of locations. The business model is multifaceted, generating revenue from three primary streams: Imaging Center Services, Imaging Solution Services, and Rimag Cloud Services. Imaging Center Services, the largest revenue contributor, involves providing direct examination and diagnostic services to patients and offering operational management for partner centers. Imaging Solution Services assists medical institutions with the selection, procurement, and maintenance of imaging equipment, alongside providing modular solutions to maximize equipment value. The Rimag Cloud platform, commercialized in 2018, underpins the entire network by offering remote diagnostics, cloud storage for medical images, and data-driven operational management tools to improve efficiency for their healthcare clients.

Rimag serves a diverse client base that includes patients, individual healthcare consumers, and medical institutions such as hospitals and clinics. By establishing flagship centers in major cities and a variety of shared and specialized centers in smaller regions, the company aims to bridge the gap in medical resources and support China's hierarchical diagnosis and treatment system. The company has attracted substantial investment from prominent backers including Goldman Sachs, Baidu Capital, JD Health, and CICC Capital. Facing a rapidly growing market, Rimag is focused on expanding its network and enhancing its technological capabilities to solidify its position as a comprehensive medical imaging platform operator.